APA (7th ed.) Citation

Ottmann, O. G., & Heidenreich, D. (2014). 798 Nilotinib (Tasigna®) and chemotherapy for first-line treatment in elderly patients with De Novo Philadelphia Chromosome/BCR-ABL1 positive acute lymphoblastic leukemia (ALL): A trial of the European Working Group for Adult ALL (EWALL-PH-02). Blood, 124(21), .

Chicago Style (17th ed.) Citation

Ottmann, Oliver G., and Daniela Heidenreich. "798 Nilotinib (Tasigna®) and Chemotherapy for First-line Treatment in Elderly Patients with De Novo Philadelphia Chromosome/BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL): A Trial of the European Working Group for Adult ALL (EWALL-PH-02)." Blood 124, no. 21 (2014).

MLA (9th ed.) Citation

Ottmann, Oliver G., and Daniela Heidenreich. "798 Nilotinib (Tasigna®) and Chemotherapy for First-line Treatment in Elderly Patients with De Novo Philadelphia Chromosome/BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL): A Trial of the European Working Group for Adult ALL (EWALL-PH-02)." Blood, vol. 124, no. 21, 2014.